Oyster Point Pharma, Inc.
OYSTDelisted Jan 3, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001720725
Oyster Point Pharma, Inc. was delisted on Jan 3, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 53 institutions reported holding it in 13F filings for Q4 2022, worth $189.4M in total; no superinvestor held it.
Q1 2025 vs. Q4 2024
How the institutions holding Oyster Point Pharma, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 1 | 1 | 0 |
| Shares | 1 | 1 | 0 (0.0%) |
| Value | $11 | $11 | $0 (0.0%) |
New holders (0)
Institutions that held Oyster Point Pharma, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
None.
Sold out (0)
Institutions that held Oyster Point Pharma, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
None.